Connect with us

Health

Ernest Drucker, Public-Health Advocate for the Scorned, Dies at 84

Published

on

Ernest Drucker, Public-Health Advocate for the Scorned, Dies at 84

Ernest Drucker, a pioneering public-health researcher who approached drug addiction with compassion, invigorated needle-exchange programs to stem the AIDS epidemic and diagnosed the destructive impact of what he called a “plague” of mass incarceration, died on Jan. 26 at his home in Manhattan. He was 84.

The cause was complications of dementia, his son, Jesse Drucker, said.

For more than three decades, Dr. Drucker, primed with epidemiological evidence, waged cutting edge campaigns to improve the lot of prison inmates; the homeless; patients with tuberculosis; workers exposed to asbestos; and HIV-infected drug users and their families, who had been ravaged by the repercussions of AIDS. He was an early and vocal proponent of rethinking the country’s approach to illicit drugs, advocating “harm reduction” — a strategy that prioritizes reducing negative consequences over criminal prosecution.

A clinical psychologist by training, he was professor emeritus of family and social medicine at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx and had been a senior research associate and scholar in residence at John Jay College of Criminal Justice of the City University of New York in Manhattan, where he biked to work from the Upper West Side.

Dr. Helene Gayle, an epidemiologist and a former president of Spelman College in Atlanta, described Dr. Drucker this way in an email to his son: “Unapologetic about taking on issues that others wouldn’t touch. Unapologetic about the humanity in all including those who had suffered the most injustice.”

Advertisement

Having run a drug rehabilitation program in the Bronx, Dr. Drucker knew firsthand the destructive capabilities of addictive drugs. But the criminal prosecution of addicts, he argued, only compounded the problem, forcing addicts underground, where dangerous practices like sharing needles resulted in the spread of H.I.V., and saddling them with criminal records that could make them unemployable.

“Our demonization of heroin has transformed otherwise benign and controllable patterns of its use into a lethal gamble and has raised the threshold for seeking help when problems do arise,” he wrote in a letter to The New York Times in 1995. “Other countries are adopting ‘harm reduction’ strategies that (without legalizing drugs) acknowledge their widespread use and employ methods (such as needle exchange) to make even injectable use safer.”

He added that “our stubborn failure to acknowledge the enduring appeal of drugs, and learn how to control (rather than prohibit) their use” had tragic consequences.

Instead, he contended in his book “A Plague of Prisons: The Epidemiology of Mass Incarceration in America” (2011), that for the 90 percent of drug crimes that are nonviolent “criminalization can be replaced with a public health and therapeutic model.”

Dr. Drucker established some of the world’s first syringe exchange programs and in 1991, after he testified in favor of them, four members of the AIDS Coalition to Unleash Power, known as Act Up, were acquitted in Jersey City, N.J., of charges related to running a needle exchange program to prevent the spread of AIDS.

Advertisement

He warned that the AIDS epidemic was not only afflicting gay men but was also increasingly devastating poor, nonwhite families. He said that heterosexual relations in certain Bronx neighborhoods had become a form of “sexual Russian roulette” that was orphaning children.

“No one, by a long shot, spun out more novel ideas for research, policy and advocacy, many of which resulted in influential publications, new organizations and changes in policy on all aspects of harm reduction as well as drug treatment, public health and criminal justice reform,” Ethan A. Nadelmann, the founder of the Drug Policy Alliance, which has opposed the war on drugs, said in an email.

Dr. Drucker was a founder and chairman of Doctors of the World/USA from 1993 to 1997, was the founding editor in chief of Harm Reduction Journal, and a founder of the International Harm Reduction Association.

In his eulogy, Professor David Michaels of George Washington University’s Milken Institute School of Public Health and a former administrator of the federal Occupational Safety and Health Administration, said Dr. Drucker was “a true public health Renaissance man, driven by a deep commitment to fairness, and justice. He cared deeply about people — you can see it in his work on harm reduction, insisting we should not punish people for who they are and the decisions they make, but instead we should help them become healthier and more fulfilled.”

Ernest Mor Drucker was born on March 29, 1940, in Brooklyn. His father, Joseph, was a machinist for ITT. His wife, Beatrice (Strull) Drucker, managed the household.

Advertisement

Ernest was raised in the borough’s Brighton Beach section, and graduated from Brooklyn Technical High School with plans to become an engineer, but he gravitated toward psychology as a major at City College of New York, where he earned a bachelor’s degree in 1962 followed by a doctorate.

At Montefiore/Einstein, where he was a disciple of Drs. H. Jack Geiger and Victor Sidel, two proponents of health care for the poor, he was the director of Public Health and Policy Research and the founding director of a 1,000-patient drug treatment program, where he served until 1990.

He would periodically reinvent himself professionally, shifting his focus to and from heroin addiction, public health, occupational safety, AIDS and alternatives to prison.

In addition to his son, Jesse, an investigative reporter for The New York Times, he is survived by his wife, Jeri (Rosner) Drucker, an artist; his brother, Alan Drucker; and two grandchildren.

Advertisement

Health

Flu hospitalizations hit all-time weekly high in densely populated state, officials warn

Published

on

Flu hospitalizations hit all-time weekly high in densely populated state, officials warn

NEWYou can now listen to Fox News articles!

The New York State Department of Health has announced the highest number of flu hospitalizations recorded in a single week.

The state confirmed the uptick in hospital visits in a press release on Jan. 2, as flu cases continue to rise in the region and nationwide.

New York State, including New York City, has consistently tracked the highest numbers of recorded respiratory illness cases in the country for the last few weeks, according to CDC data. Several other states have climbed to the “very high” category for respiratory activity as well, as of the week ending Dec. 27.

RECORD-BREAKING FLU NUMBERS REPORTED IN NEW YORK STATE, SPARKING WARNINGS FROM OFFICIALS

Advertisement

The most recent data from the New York health department showed a total of 4,546 hospitalizations from Dec. 26, 2025, to Jan. 2, 2026 – a week-over-week increase of nearly 1,000. The prior week, the department announced the highest number of flu cases ever recorded in a single seven-day period.

The New York State Department of Health reported a total of 4,546 hospitalizations from Dec. 26, 2025, to Jan. 2, 2026. (iStock)

In a statement, New York’s Acting Commissioner of Health Dr. James McDonald noted the severity of this flu season compared to previous years.

“Almost 1,000 more people were admitted to a hospital during this most recent seven-day period compared to the prior week,” he confirmed. “There is still time to get a flu shot, and remember, flu can be treated with antiviral medication if started within 48 hours of symptom onset [as] your doctor deems appropriate.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Health officials are pushing for Americans to consider getting the flu vaccine, as experts consider it to be a top line of defense for preventing viral exposure and spread.

Flu symptoms can include fever, chills, headache, fatigue, cough, sore throat and runny nose. (iStock)

In a previous interview with Fox News Digital, Dr. Neil Maniar, professor of public health practice at Boston’s Northeastern University, emphasized that it’s not too late to get the flu vaccine, as peak season typically occurs in January.

“The vaccine still provides protection against serious illness resulting from the subclade K variant that seems to be going around,” he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

Even healthy individuals can become seriously ill from the flu, Maniar noted, “so a vaccine is beneficial for almost everyone.”

“Individuals typically start to develop some degree of protection within a few days and gain the full benefit within about two weeks, so now is the time for anyone who hasn’t gotten the vaccine yet.”

“The vaccine still provides protection against serious illness resulting from the subclade K variant that seems to be going around,” one doctor said. (iStock)

Flu symptoms can include fever, chills, headache, fatigue, cough, sore throat and runny nose.

A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, causing more intense symptoms and higher risk of spread.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“It’s becoming evident that this is a pretty severe variant of the flu,” Maniar said. “Certainly, in other parts of the world where this variant has been prevalent, it’s caused some severe illness, and we’re seeing an aggressive flu season already.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

New York State recommends taking preventive actions to avoid flu infection. These include washing hands often; avoiding touching the eyes, nose and mouth; avoiding close contact with sick people; cleaning and disinfecting objects and surfaces; and staying home when feeling sick.

Advertisement
Continue Reading

Health

Not all cancers should be treated right away, medical experts say — here’s why

Published

on

Not all cancers should be treated right away, medical experts say — here’s why

NEWYou can now listen to Fox News articles!

When someone gets a cancer diagnosis, the initial reaction is usually to undergo treatment as quickly as possible — but for some types of disease, doctors may recommend a more conservative approach.

For certain cancers, immediate or aggressive treatment can cause more harm than good, according to multiple medical experts.

For example, treating slow-growing tumors with surgery, radiation or chemotherapy could create significant side effects without a survival benefit.

PROSTATE CANCER PATIENTS SEE LONGER SURVIVAL WITH NEW COMBINATION DRUG 

Advertisement

“The fact that so many cancers will never kill you is not a justification for not knowing, because there is still plenty of room for ‘watchful waiting,’ as well as interventions that may improve quality of life even if they don’t extend life,” Dr. Marc Siegel, Fox News senior medical analyst, told Fox News Digital.

This is especially true as targeted cancer treatments emerge, which are more personalized and less likely to cause severe side effects, according to the doctor.

For precancerous, very early-stage breast conditions, careful monitoring may be more prudent than immediate surgery, research shows. (iStock)

“The fact that cancers are occurring earlier is a justification for heightened screenings, not the opposite,” Siegel added. “Information is power — what you do with that information is based on clinical judgment and the art of medicine.”

Below are some types of cancer that may not warrant treatment, according to research and doctors’ guidance.

Advertisement

No. 1: Prostate cancer (low-risk)

While some types of prostate cancer should be treated right away, others are better addressed by “watchful waiting,” according to Sanoj Punnen, M.D., a urologic oncologist with Sylvester Comprehensive Cancer Center, part of the University of Miami Health System. 

“With respect to prostate cancer, for most low-risk cancers (Gleason 6 or grade group 1), we recommend initial observation and surveillance rather than immediate treatment,” he told Fox News Digital.

NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDS

The Gleason score is a grading system that ranks prostate cancer cells in terms of how abnormal they are, with 6 being the lowest grade and 10 being the highest grade (barely resembling normal cells).

“For high-grade tumors like Gleason 8, 9 or 10, we believe they progress quickly, so we recommend treatment to prevent the risk of metastasis,” said Punnen, who is also vice chair of research and a professor with the Desai Sethi Urology Institute at UHealth. “For low-risk tumors, we think they pose little risk, so we recommend just observation.”

Advertisement

“The fact that cancers are occurring earlier is a justification for heightened screenings, not the opposite.”

“But in the end, we can’t be sure, so our approach to observation includes serial monitoring of cancer status with PSA, MRI and occasional biopsy to ensure the tumor isn’t progressing.”

No. 2: Ductal carcinoma in situ (DCIS) 

Also known as stage 0 breast cancer, DCIS is a non-invasive disease marked by abnormal cells in the lining of the breast milk ducts. The “in situ” is Latin for “in the original place,” which indicates that the cancer has not spread outside the milk ducts.

For this precancerous, very early-stage breast condition, careful monitoring may be more prudent than immediate surgery, research shows.

While some types of prostate cancer should be treated right away, others are better addressed by “watchful waiting,” according to a urologic oncologist. (iStock)

Advertisement

A 2024 study by the Dana-Farber Cancer Institute found that active monitoring for DCIS resulted in similar quality of life, mental health and symptom progression over a two-year period compared to a standard surgical approach.

NEW STUDY QUESTIONS WHETHER ANNUAL MAMMOGRAMS ARE NECESSARY FOR MOST WOMEN

“These results suggest that in the short term, active monitoring is a reasonable approach to management of low-risk DCIS,” the lead researcher said in a press release. “If longer-term follow-up supports the safety of active management from a cancer outcome standpoint, this approach could be considered as an option for women with this condition.”

“But it is also critical that we understand how women feel when they are living with this ‘watch and wait’ approach and how it impacts their overall quality of life.”

Other research has suggested that women with low-risk DCIS did not have a higher rate of invasive cancer after two years of active monitoring, although each patient should discuss their individual risk level with an oncologist.

Advertisement

No. 3: Indolent (slow-growing) lymphomas

Non-Hodgkin lymphoma (NHL) is a type of cancer that starts in the lymphatic system, which includes the lymph nodes, spleen, thymus, bone marrow and other tissues. 

Indolent lymphomas are those that “grow and spread slowly,” according to the American Cancer Society.

THE DEADLY CANCER HIDING IN PLAIN SIGHT — AND WHY MOST PATIENTS NEVER GET SCREENED

The National Comprehensive Cancer Network (NCCN) recommends watchful waiting for asymptomatic, slow-growing follicular lymphoma, as a means of avoiding the toxicity of chemotherapy and immunotherapy until it’s absolutely necessary.

The Lymphoma Research Foundation confirms that doctors recommend “active surveillance” for some patients with slow-growing lymphoma.

Advertisement

Indolent lymphomas are those that “grow and spread slowly,” according to the American Cancer Society. (iStock)

“This approach may be started after the initial diagnosis or after relapse, depending on the situation,” the foundation states on its website. “Active treatment is started if the patient begins to develop lymphoma-related symptoms or if there are signs that the disease is progressing.”

Treatment should be started right away for aggressive (fast-growing) lymphomas.

No. 4: Chronic lymphocytic leukemia

One of the most common adult leukemias, chronic lymphocytic leukemia (CLL) originates in white blood cells (lymphocytes) in the bone marrow and then spreads to the bloodstream, according to the American Cancer Society.

CLL tends to grow slowly, with many patients experiencing no symptoms for years. Eventually, the cancer calls can spread to the lymph nodes, liver and spleen.

Advertisement

BREAKTHROUGH BLOOD TEST COULD SPOT DOZENS OF CANCERS BEFORE SYMPTOMS APPEAR

Some studies have shown that early treatment for CLL does not improve survival rates compared to observation, and that the benefits may not outweigh the risks.

In a 2023 study presented at the European Hematology Association 2023 Congress in Frankfurt, Germany, researchers found that early treatment did not prolong overall survival compared to a placebo in patients with early, asymptomatic CLL.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“I believe it’s fair to conclude that ‘watch-and-wait’ should remain the standard of care in the era of targeted drugs,” said researcher Petra Langerbeins, M.D., when presenting the findings.

Advertisement

No. 5: Low-grade endometrial cancer

For most patients with endometrial cancer, surgery is the first treatment, which entails removing the uterus, fallopian tubes and ovaries, according to the American Cancer Society.

However, in certain patients with low-grade cancer, such as older people, those with “frailty” and people with major health issues, doctors may recommend deferring surgery, which can pose a high risk.

The American Thyroid Association’s guidelines officially recommend active surveillance for very low-risk microcarcinomas. (iStock)

In cases where the patient has medical comorbidities or wants to preserve fertility, hormone treatment may be used instead of surgery, per the ACS.

“It’s usually also considered for cancer that is lower-grade, low-volume and slow-growing,” the above source stated.

Advertisement

No. 6: Some early kidney cancers

In cases of kidney cancer with small tumors (≤3 cm) or benign lesions, doctors may recommend monitoring them instead of undergoing surgery for removal.

CLICK HERE FOR MORE HEALTH STORIES

The American Urological Association confirms that active surveillance is an option for some small renal masses (localized tumors).

“I believe it’s fair to conclude that ‘watch-and-wait’ should remain the standard of care in the era of targeted drugs.”

Deferred treatment is particularly recommended for older patients or those with “significant comorbidities,” research shows.

Advertisement

“Shared decision-making about active surveillance should consider risks of intervention/competing mortality versus potential oncologic benefits of intervention,” the UAU states in its guidance.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Data from the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry showed that patients with active surveillance had a 99% or greater cancer-specific survival rate — virtually the same as patients who received immediate treatment.

No. 7: Small papillary thyroid cancers

Papillary thyroid cancer (PTC), the most common type of thyroid cancer, may not warrant treatment for small tumors measuring 1 centimeter (10 mm) or less, which are called microcarcinomas.

A young multiracial female is undergoing a diagnostic medical imaging procedure in a state-of-the-art hospital setting with CT simulator. The image illustrates the use of cutting-edge technology for healthcare and treatment in a modern medical environment. The portrayal highlights precision, care, and the sophistication of contemporary medical practices. (iStock)

Advertisement

Research found that when using active surveillance for 10 to 20 years, less than 10% experienced significant growth, only 5% developed lymph node spread and there were no thyroid-cancer deaths.

The American Thyroid Association’s guidelines officially recommend active surveillance for very low-risk microcarcinomas.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

While many patients with low-risk tumors can safely delay treatment, this does not apply to all cancers or all patients. 

As cancer behavior and personal health factors vary widely, patients should consult their doctor to determine the most appropriate course of care based on their individual risk level.

Advertisement

Continue Reading

Health

Brain Health Challenge: Test Your Knowledge of Healthy Habits

Published

on

Brain Health Challenge: Test Your Knowledge of Healthy Habits

Welcome to the Brain Health Challenge! I’m Dana Smith, a reporter at The New York Times, and I’ll be your guide.

To live a healthy life, it’s crucial to have a healthy brain. In the short term, it keeps you sharp and firing on all cylinders. In the long term, it can reduce your risk of cognitive decline, dementia and stroke.

Advertisement

Practicing basic healthy behaviors, like eating nutritious food and getting regular exercise, is the best way to enhance your brain power and protect the longevity of your neurons. These types of lifestyle habits can benefit the brain at any age. And while they won’t guarantee that you’ll never develop dementia or another brain disease, several clinical trials have shown that they can improve cognition or slow decline.

Every day this week, you’ll do an activity that’s good for your brain, and we’ll dig into the science behind why it works. Some of these activities can provide a small immediate cognitive benefit, but the bigger reward comes from engaging in them consistently over time. So along with the neuroscience lessons, we’ll include a few tips to help you turn these actions into lasting habits.

To keep you accountable, we’re encouraging you to complete this challenge with a friend. If you don’t have a challenge buddy, no problem: We’re also turning the comments section into one big support group.

Advertisement

There are so many fascinating ways your daily behaviors affect your brain. Take sleep, for example.

Lots of studies have shown that getting a good night’s rest (seven to eight hours) is associated with better memory and other cognitive abilities. That’s because sleep, especially REM sleep, is when your brain transfers short-term memories — things you learned or experienced during the day — into long-term storage.

Advertisement

Sleep is also when your brain does its daily housekeeping. While you rest, the brain’s glymphatic system kicks into high gear, clearing out abnormal proteins and other molecular garbage, including the protein amyloid, which is a major contributor to Alzheimer’s disease. A buildup of amyloid is one reason experts think that people who routinely get less sleep have a higher risk of dementia.

What other behaviors play a big role in brain health? For today’s activity, we’re going to test your knowledge with a quiz. Share your score with your accountability partner and in the comments below — I’ll be in there too, cheering you on.

Continue Reading
Advertisement

Trending